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Abstract
Nitric oxide (NO) affects fatty acid synthesis and biogenesis of fatty acid consuming mitochondria. However, whether NO generated by the
endothelial NO synthase isoform (eNOS) has significant impact on the synthesis and deposition of fat in liver remained unclear. We analyzed the
quantity and distribution of mitochondria and fat in liver of wild-type (WT) mice and mice lacking eNOS (eNOS-KO). The livers of eNOS-KO
mice contained tenfold more fat close (zone 1) and twenty fold more distal (zone 3) to the artery. The fat was deposited as droplets co-localized
with mitochondria. Additionally, the livers of eNOS-KO mice contained 1.5-fold more homogenously distributed glycogen. No difference in the
quantity of mitochondria was found between liver homogenates of eNOS-KO mice and WT animals. Mitochondria from liver homogenates of
eNOS-KO mice exhibited a higher ratio of citrate synthase (CS) and NADH–cytochrome c oxidoreductase (KI+III) activity. We conclude that
lack of eNOS-derived NO stimulates citrate- and lipid synthesis in liver thus contributing to the development of overweight. In support of this
view, more visceral fat and 70% higher body weight was determined in one year old eNOS-KO mice in comparison to WT animals.
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There are reports that point towards a regulatory effect of NO
in lipid metabolism in liver. It has been shown that NO attenuates
the synthesis of fatty acids in isolated cultured rat hepatocytes by
nitrosylation of acetyl-CoA thereby converting this metabolite to
the biologically inactive S-nitroso-CoA [1]. A second mechan-
ism for NO mediated inhibition of fatty acid synthesis is the
activation of AMP-activated protein kinase. As a result the
cellular level of malonyl-CoA and the activity of fatty acid
synthesis are reduced and conversely fatty acid oxidation is
stimulated [2]. NO can stimulate AMP-activated protein kinase
activity via gene expression [3] and via the generation of pe-
roxynitrite [4]. Additionally, activation of the AMP-activated⁎ Corresponding author. Tel.: +49 391 6713644; fax: +49 391 67290176.
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doi:10.1016/j.bbadis.2007.12.007protein kinase inhibits glycerol-3-phosphate acyltransferase and
concomitantly triacylglycerol synthesis [5,6]. In our own experi-
ments we have demonstrated that NO causes inhibition of fatty
acid synthesis in liver at the mitochondrial level. Applying a
neuronal NO synthesis knock out (nNOS-KO) model, we have
shown that NO contributes to the adjustment of low rates of fatty
acid synthesis by limiting citrate synthesis in mitochondria [7].
This could be, at least in part, the mechanism by which the lipid
content in liver is regulated. In fact, a lower content of lipids was
found in the liver of WT mice in comparison to nNOS-KO mice
but without any consequence on body weight [7].
Stimulation of mitochondrial biogenesis by endogenous NO
has been reported for several tissues including liver [8]. It has
been suggested that an increase in the number of mitochondria
enhances energy production thus promoting the oxidation of
fatty acids. In line with this hypothesis is the observation by the
authors thatWTmice had a significantly lower body weight than
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require a higher energy demand. Currently, there is no convinc-
ing evidence for a metabolically founded higher energy demand
in WT mice versus eNOS-KO mice. Moreover, it is still unclear
whether NO originated from eNOS is involved in the regulation
of lipid deposition in liver and how mitochondria contribute to
this process.
In order to investigate the effect of NO generated by eNOS
on mitochondria we determined not only the quantity but also
the distribution of mitochondria in the livers of WT mice and
eNOS-KO mice by applying electron microscopy analysis. The
cellular amount of mitochondria was independently estimated
by determining the ratio of nuclear and mitochondrial DNA in
liver homogenates of WTand eNOS-KOmice. Furthermore, we
investigated whether mitochondria from the livers of WT and
eNOS-KO mice differ in their enzymatic composition. In this
context we focused on the determination of the activities of CS
and KI+III since an excess of citrate can serve as substrate for
cytosolic fatty acid synthesis. We have found significant differ-
ences in the ratio of the activities of both enzymes as well as in
the local distribution of mitochondria in the livers between WT
and eNOS-KO mice but not in the amount of mitochondria. The
next series of experiments was aimed to analyze the content and
local distribution of fat and glycogen in the livers of WT and
eNOS-KO mice. The livers of eNOS-KO mice contained much
more glycogen and fat. The latter was inhomogenously distri-
buted and found predominantly localized in zone 3 (distal to the
artery) according to Rappaport's nomenclature. Finally, we
searched for systemic consequences of the NO-dependent dis-
tribution of mitochondria, glycogen and fat in liver by measur-
ing body weight as well as insulin, triacylglycerol, and glucose
in the blood of WT and eNOS-KO mice. Differences were
found in body weight, insulin and glucose levels but not in the
triacylglycerol content between WT and eNOS-KO mice. Our
data suggest that the impact of NO on mitochondria contributes
in the control of lipid metabolism in liver and body weight.
2. Methods
2.1. Animals
The experiments were performed using male laboratory bred homozygous
eNOS-KO (C57BL/6 background) and nNOS-KO (C57BL/6,129S background)
mice [9,10] and WT mice (C57BL/6 background). All animals were maintained
at 21 °C in accordance with the guidelines of the German Animal Welfare Act.
The experimental protocol was approved by a review committee of the state
of Sachsen-Anhalt, Germany. With exception of age dependent investigations
120–140 day old animals were used. For the study, the mice were sacrificed by
decapitation or by overdosed anesthesia with pentobarbital intraperitoneally.
2.2. Histological analysis
The liverswere removed and fixed either in 3%paraformaldehyde for paraffin
embeddedH&E sections or Sudan red stained frozen sections, or theywere fixed
in 2.5% glutaraldehyde and OsO4 for Epon 812 embedded semithin and thin
sections. Semithin sections were stained according to Richardson [11], ultrathin
sections were stained with lead citrate and uranyl acetate, and examined with a
Zeiss EM900 electron microscope. For the determination of the volume fractions
occupied by mitochondria, fat and glycogen the stereological method of Weibel
was used [12]. At least 600 points were analyzed for the calculation.2.3. Preparation of liver homogenates
The extracted tissues were minced using small scissors and transferred
into ice cold phosphate buffer solution (PBS) at pH 7.4. Subsequently, the
tissues were homogenized at 4 °C using a Potter-Elvehjem glass-teflon ho-
mogenizer performing 10 strokes at 600 rpm. After determination of protein,
all samples were adjusted to identical protein content by adding adequate
amounts of PBS.
2.4. Determination of protein
The protein content of the samples was determined by the Pierce bicincho-
ninic acid protein assay [13] using bovine serum albumin as the standard.
2.5. Determination of citrate synthase activity (EC 2.3.3.1)
Citrate synthase activitywas assayed using a standard procedure at 30 °C [14].
Homogenate samples of respective tissues (40 μg) were evaluated. The decrease
of acetyl-CoA absorption was monitored at 412 nm using a Cary 1E spectral
photometer (Varian). The reaction mixture contained 100 mM Tris–HCl buffer
(pH 8.0), 5 mM MgCl2, 0.5 mM 5,5-dithio-bis-2-nitrobenzoic acid (DTNB),
0.2 mM acetyl-CoA, and 1 mM oxaloacetic acid.
2.6. Determination of NADH:cytochrome c oxidoreductase activity
(EC 1.6.99.3)
Samples of 500μl were drawn from the homogenates. Themitochondriawere
disintegrated by sonication. A 15 μl volume (40 μg protein) was used to run the
assay at 30 °C as described in [15]. The reduction of cytochrome c was followed
by measurement of the absorption at 550 nm with a Varian spectrophotometer
(Cary 1E). The rotenone-sensitive absorption was used for quantification.
2.7. Mitochondrial/nuclear DNA ratio
Determination of the ratio between mitochondrial and nuclear DNA contents
was performed by quantitative real-time PCR, essentially as described by others
[16,17]. For DNA isolation, whole tissue samples from each eight wild-type and
eNOS−/− mice were powdered in liquid nitrogen and 25 mg aliquots were used
for DNA extraction by means of the QIAamp DNA Mini Kit (Qiagen, Hilden,
Germany). For each DNA extract, the nuclear gene for ribosomal protein large p0
and the mitochondrial gene cytochrome c oxidase subunit I (CoxI) were quan-
tified separately by real-time PCR using the iCycler (Bio-Rad, Munich, Ger-
many). The PCR reactions were performed in triplicate for each gene. A typical
25-μl reactionmixture contained 12.5μl HotStarTaqMasterMix (Qiagen), 0.3 μl
of a 1:1000 dilution of SYBR Green I (Molecular Probes, Eugene, Oregon),
100 ng DNA, and 0.5 μmol of the specific primers: p0-US 5′-GCACTTTCGC-
TTTCTGGAGGGTGT-3′ and p0-DS 5′-TGACTTGGTTGCTTTGGCGGGATT-3′;
CoxI-US 5′-TCTACTATTCGGAGCCTGAG-3′ and CoxI-DS 5′-CTACTGATgCT-
CCTGCATGG-3′. An initial denaturation/activation step (15 min 95 C) was
followed by 40 cycles (30 s 95 C, 30 s 58 C, and 45 s 72 C).
2.8. Determination of triacylglycerol
The content of triacylglycerol in the serum was determined according to
[18]. The serum from non-fasted WT and eNOS-KO mice was obtained by
centrifugation for 10 minutes at 3000 ×g. All blood samples were collected in
the morning within 30 minutes. Subsequently the samples were hydrolyzed with
ethanolic KOH (0.5 M) and after 30 minutes of incubation at 70 °C neutralized
(pH 7) with perchloric acid (2.5 M). The content of glycerol of 100 μl samples
was determined in a reaction mixture with a final volume of 1 ml containing:
71.4 mM triethanolamine, 8.5 mM Mg2+, 1.0 mM phosphoenolpyruvate,
0.4 mM NADH, 2.0 mM ATP, 5 U pyruvate kinase, 5 U lactate dehydrogenase
and 0.5 U glycerol kinase. The absorption of NADH was measured at room
temperature with a Varian spectrophotometer (Cary 1E) at a wavelength of
340 nm. For the calculation of triacylglycerol content the difference of free and
bound glycerol was used.
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Serum samples from trunk blood were collected at sacrifice. Blood glucose
was determined immediately after sacrifice with a Biosen 5030 glucose analyzer
(EKF-diagnostic GmbH, Barleben/Magdeburg, Germany) employing the glu-
cose oxidase method as principle of measurement.
2.10. Determination of insulin
Serum insulin concentration was determined by means of a commercial
radioimmuno-assay (RIA) suitable for mouse insulin (Rat Insulin RIA Kit,
LINCO Research, St. Charles, MO, USA). All determinations were performed
in duplicate; the manufacturer's protocol was adapted to smaller sample sizes.
2.11. Statistical analysis
Statistical analysis was carried out with ANOVA test with two-way layout
combined with post hoc Tukey test. For the comparison of parameters from
eNOS-KO mice and WT mice unpaired Student's t test was used. Detailed
information is given in the legends of Figures and Tables. Data is presented asFig. 1. Effect of endogenous NO on the distribution of fat and mitochondria in he
Rappaport) of WT mice (A), zone 1 of nNOS-KO mice (B), zone 3 of eNOS-KO
magnification was used. The length of the bar corresponds to 1 μm. Fat deposits in
Mitochondria (arrow heads) were co-localized with the fat droplets.means±SEM. Statistical analysis of differences with pb0.05 was taken as the
indicator of significance.
3. Results
3.1. Endogenous NO from eNOS controls distribution and
enzymatic pattern of liver mitochondria
To study the effect of endogenous NO originated from eNOS
on mitochondria in liver, we first analyzed the ratio between
mitochondrial and nuclear DNAby applying real-time PCR. This
ratio reflects the quantity of mitochondria per cell. In contrast to
Nisoli et al. [8], we did not find any significant difference in the
amount of mitochondria by comparing the ratio of mitochondrial
and nuclear DNA in liver homogenates fromWTand eNOS-KO
mice (triplicates from three animals per mouse model), (WT:
54.08±2.02 versus eNOS-KO: 53.63±1.57). Additionally, wepatocytes. Electron micrographs of the liver from acinar zone 3 (according to
mice (C), and zone 1 of eNOS-KO mice (D) are shown. In all cases the same
form of membraneless droplets (asterisks) were predominantly found in zone 3.
Table 1
Effect of eNOS-derived NO on the distribution and enzymatic pattern of
mitochondria in liver
WT eNOS-KO
Mitochondria (% of cytosolic volume)
Zone 1 28.27±1.05 17.07±0.99⁎
Zone 3 29.80±0.80 37.06±1.34
Zone 1+zone 3 29.03±0.93 27.07±1.12
CS (μMol mg−1 min−1) 0.0574±0.0074 0.0454±0.0023⁎
KI+III (μMol mg−1 min−1) 0.276±0.023 0.163±0.011⁎
CS/KI+III 0.208±0.021 0.279±0.019⁎
The distribution of mitochondria was analyzed on the base of electron micro-
graphs. Three animals per group were evaluated for this investigation. For the
determination of the activities of CS and KI+III liver homogenates were pre-
pared. Five livers were used for each group. The data are presented as mean±
SEM. Differences between parameters of eNOS-KO and WT mice were
analyzed by applying unpaired Student's t test. ⁎difference between WT and
eNOS-KO mice is significant with pb0.05.
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distribution of mitochondria within the hepatocytes. Electron
micrographs from hepatocytes of WT, nNOS-KO, and eNOS-
KO mice are presented in Fig. 1. Since the local concentration of
NO results from different sources the liver of nNOS-KO mice
was included in the analysis (Fig. 1B). Fat deposition in form of
droplets (indicated with asterisks) is seen in the cytosol of hepa-
tocytes of WT and eNOS-KO mice but not in the liver of nNOS-
KO mice. It is remarkable that mitochondria (arrow heads) and
fat drops are clearly co-localized (Fig. 1A and C). The detailed
analysis of the areas of the cytosol (without glycogen and fat) thatFig. 2. Effect of endogenous NO on fat deposition in liver tissue. Semithin sections sta
prepared for histological analysis of the livers from WT, nNOS-KO, and eNOS-KO
C: eNOS-KO; D: eNOS-KO. Massive fat deposition is documented in zone 3 of theare occupied by mitochondria revealed a clear distribution of
mitochondria within the tissue (Table 1). We found no significant
difference in the quantity and distribution of mitochondria be-
tweenWTand nNOS-KOmice.However, the livers of eNOS-KO
mice contained in zone I which is closest to the artery (according
to Rappaport's nomenclature) significantly less and in zone 3
(distal to the artery) more mitochondria than the liver of WT
animals.
In the next series of experiments we investigated whether
mitochondria from WT and eNOS-KO mice differ in their
enzymatic pattern. Since citrate produced in the mitochondrial
matrix can serve as substrate for cytosolic fatty acid synthesis
the relationship between the activities of the citric acid cycle and
the respiratory chain was analyzed. Therefore, the activity of CS
and KI+III was determined from liver homogenates of WT and
eNOS-KO mice. The liver homogenates of WT mice had higher
activities of CS and KI+III in comparison to eNOS-KO mice
(Table 1). However, the ratio of CS activity and KI+III activity
was significantly higher in the homogenates of eNOS-KO mice
(0.279±0.019 for eNOS-KO versus 0.208±0.021 for WT).
Although these data from the tissue homogenates do not reflect
specificities of liver architecture it may be suggested that the
relative excess of citric acid cycle enzymes promotes fatty acid
synthesis in eNOS-KO mice.
3.2. Endogenous NO from eNOS determines fat and glycogen
deposition in liver
On the basis of these findingswewere interested to investigate
the deposition of fat in liver fromWT, nNOS-KO, and eNOS-KOined according to Richardson (A–C) or Sudan red stained cryo-sections (D) were
mice. The width of the pictures corresponds to 810 μm. A: WT; B: nNOS-KO;
livers only from eNOS-KO mice.
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analyzed by light microscopy. The staining according to Richard-
son revealed massive fat deposition in zone 3 of the liver from
eNOS-KO mice (Fig. 2C) whereas no such fat deposits were
observed in the livers of WT and nNOS-KO mice (Fig. 2A and
B). Massive fat deposition in zone 3 of livers from eNOS-KO
mice was confirmed by the fat-specific Sudan red staining
(Fig. 2D).
Electron micrographs of the livers were statistically analyzed
for the quantification of fat deposition. The volume fraction ofFig. 3. Effect of eNOS-derived NO on the distribution of fat and glycogen in
liver. Areas of the cytosol (without nucleus) occupied by fat or glycogen are
determined in electron micrographs of liver fromWT, nNOS-KO and eNOS-KO
mice. Zone 1 and zone 3 were analyzed. Additionally, mean values of zone 1 and
zone 3 (zone 1+zone 3) are presented. Data were accumulated from 3 animals
per group and were presented as mean±SEM. Statistical analysis was performed
using ANOVA for repeated measurements considering zones as within-factor
and genotypes as between-factor. Tukey test for pair wise comparison of geno-
type was used as post hoc test. Additionally, differences between zone 1 and 3
were separately tested using simple paired t test. ⁎difference is significant for
eNOS-KO versusWTand eNOS-KO versus nNOS-KO for zone 1; ⁎⁎ difference
is significant for eNOS-KO versus WT and eNOS-KO versus nNOS-KO for
zone 3; + difference is significant for eNOS-KO versus WT and eNOS-KO
versus nNOS-KO for zone 1 plus zone 3; ++ difference is significant between
zone 1 and zone 3 in eNOS-KO mice. # difference is significant for eNOS-KO
versus WT, eNOS-KO versus nNOS-KO, and nNOS-KO versus WT for zone 1;
## difference is significant for eNOS-KO versus WT and eNOS-KO versus
nNOS-KO for zone1 plus zone 3; § difference is significant between zone 1 and
zone 3 in nNOS-KO mice.
Fig. 4. Effect of eNOS-derived NO on the accumulation of visceral fat. One year
old WT mouse (left) is compared with equal aged eNOS-KO mouse (right).the entire cytosol (without nucleus) occupied by the membrane-
less fat droplets was determined. The relative volumes of the fat
deposits in zone 1and zone 3 of the livers of WT and eNOS-KO
mice are presented in Fig. 3A. To give an impression of the fat
deposition in the tissue the mean of zone 1 and 3 are given
additionally. These mean values reveal a massive fat deposition
in the liver of eNOS-KO mice in comparison to WT mice
(33.58±1.94% of cytosol area in eNOS-KO versus 1.66±0.79%
of cytosol area in WT mice). The fat in the liver of eNOS-KO
mice was predominantly localized in zone 3 (10.87±0.69% of
cytosol area in zone 1 versus 56.30±3.27% of cytosol area in
zone3). Accordingly, the accumulation of fat was higher in zone
3 than in zone 1 with respect to WT mice (zone 1: 0.833±0.48%
of cytosol area in WT versus 10.87±0.69% of cytosol area in
eNOS-KO mice; zone 3: 2.50±1.12 of cytosol area in WT
versus 56.30±3.27% of cytosol area in eNOS-KO mice).
Accumulation of glycogen was found in the liver of eNOS-
KO mice predominantly in zone 1 (Fig. 3B, zone 1: 30.9±1.5%
of cytosol area in eNOS-KO versus 17.8±0.6% of cytosol area
in WT, p=0.007). This effect was observed in tendency also in
zone 3 (Fig. 3B, zone 3: 26.0±2.0% of cytosol area in eNOS-
KO versus 21.4±0.3% of cytosol area in WT, p=0.49). How-
ever, no significant difference in the cellular content of gly-
cogen between zone 1 and zone 3 could be detected in the livers
of eNOS-KO mice and WT mice. A significant difference in the
content of glycogen between zone 1 and 3 was only determined
in nNOS-KO mice (10.3±0.8% of cytosol area in zone1 versus
17.2±0.8% of cytosol area in zone 3, p=0.025). Taken the
average glycogen content of zone 1 and 3 as a representative of
the tissue glycogen, the livers of eNOS-KO mice contained
about 1.5 fold more glycogen in comparison to WT mice. The
Table 2
Effect of eNOS-derived NO on serum levels of glucose, triacylglycerol, and
insulin
WT eNOS-KO
Glucose (mmol/l) 9.44±0.71 7.63±0.69⁎
Triacylglycerol (mmol/l) 1.14±0.36 1.44±0.30
Insulin (ng/ml) 1.68±0.51 0.63±0.23⁎
Serum samples from trunk blood were collected at sacrifice. Five animals of
each group were analyzed. The data are presented as mean±SEM. Differences
between parameters of eNOS-KO and WT mice were analyzed by applying
unpaired Student's t test. ⁎difference between WT and eNOS-KO mice is
significant with pb0.05.
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mice suggests that glycogen metabolism does not sensitively
depend on local NO in this range of concentration.
3.3. Impairment of eNOS is associated with increase in visceral
fat and lower serum levels of glucose and insulin
Since massive fat deposition was found in the liver of
eNOS-KO mice we investigated the amount of fat in the ab-
dominal depot in WT and eNOS-KO mice. The comparison of
12 months old WT and eNOS-KO mice revealed a much higher
amount of visceral fat in eNOS-KO mice (Fig. 4). Moreover, it
is evident that eNOS-KO mice are bigger in comparison to WT
animals. To provide a quantitative parameter for this observa-
tion we determined the body weight. The body weight of male
WT, nNOS-KO, and eNOS-KO mice in dependence on age is
presented in Fig. 5. The impairment of nNOS was without
consequences on the body weight. However, loss of eNOS
expression was associated with a 1.6 fold higher body weight
of eNOS-KO mice at the age of one year. The difference in
body weight of WT and nNOS-KO mice versus eNOS-KO
mice evolved continuously with growing age. From the finding
that eNOS-KO mice but not nNOS-KO mice had a higher body
weight in comparison to WT mice it may be concluded that
eNOS contributes more to the local NO concentration in se-
veral tissues than nNOS does.
Although massive accumulation of fat was found in the liver
and abdomen in eNOS-KO mice we determined equal concen-
trations of triacylglycerol in the blood of WT and eNOS-KO
mice (Table 2). Obviously, the capacity of fat depots and lipid
transport system was not yet exceeded. In contrast, the blood
of eNOS-KO mice contained less glucose (7.63±0.69 mmol/l
in eNOS-KO mice versus 9.44±0.71 mmol/l in WT mice) andFig. 5. Effect of endogenous NO on body weight. The body weight of male WT,
nNOS-KO, and eNOS-KO mice was recorded in dependence on time. Five
animals of each group were analyzed. Data are presented as mean±SEM.
Statistical analysis was performed using ANOVAwith two-way layout with the
factors age and genotype and Tukey test as post hoc test for both factors. The
difference of body weight was significant with pb0.05 at all ages (3, 4, and
12 months) for eNOS-KO versus WT mice and eNOS-KO versus nNOS-KO
mice (asterisks). Each genotype grew significantly from point to point of
observation.insulin (0.63±0.23 ng/ml in eNOS-KO mice versus 1.68±
0.51 ng/ml in WT mice) in comparison to WT mice.
4. Discussion
It had been reported that NO is involved in the regulation of
biogenesis of mitochondria in several tissues such as brain,
heart, brown adipose tissue, and even in liver. This conclusion
was based on the finding that long term caloric restriction
causes increase of eNOS protein as well as the mitochondrial
proteins cytochrome c oxidase subunit IV and cytochrome c in
WT mice but not in eNOS-KO mice [19]. Increase of these
mitochondrial proteins was also found in several cell types
treated with a NO donor [8]. Moreover, effects of NO on the
biogenesis of mitochondria in rat skeletal muscle had been
demonstrated [20]. We did not find differences in the ratio of
mitochondrial and nuclear DNA in liver homogenates by using
real-time PCR neither between WT and nNOS-KO mice [7] nor
between WT mice and eNOS-KO mice. This ratio is a measure
of the cellular content of mitochondria. Electron microscopic
analysis revealed that mitochondria were homogenously
distributed in the liver of WT and nNOS-KO mice whereas
structure-dependent distribution of mitochondria in the liver of
eNOS-KO mice was found. The content of mitochondria was
low close to the artery (zone 1) and high in the neighborhood of
the central vein (zone 3).
It had been demonstrated that NO directly affects mitochon-
drial metabolism. NO inhibits electron transport within the res-
piratory chain at the level of the cytochrome c oxidase [21].
Further, inhibition of the mitochondrial aconitase by NO had
been reported [22,23]. In our previous work we have shown that
NO is additionally involved in the regulation of the expression of
mitochondrial enzymes. We have found different activities of
respiratory chain complexes and citrate synthase in WT and
nNOS-KO mice [7]. Likewise, we now report about different
activities of CS and KI+III in eNOS-KO and WT mice. In
contrast to nNOS-KOmice, mitochondria are not homogenously
distributed across the liver of eNOS-KOmice. Therefore, it may
be speculated that the enzymatic pattern of mitochondria differs
in dependence on the liver architecture. Our data determined in
liver homogenates do not reflect structural specialties of the
tissue and therefore may underestimate differences in the acti-
vities of mitochondrial enzymes between WT and eNOS-KO
mice.
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massive fat deposition in the liver of eNOS-KO mice. The fat
was found within the hepatocytes as membraneless fat droplets
in association with mitochondria. Moreover, the distribution of
fat clearly correlated with the distribution of mitochondria in the
liver of eNOS-KO mice. From these findings we suggest that
mitochondria are involved in fatty acid synthesis in hepatocytes.
Similar to mitochondria analyzed in liver homogenates of
nNOS-KO mice increase in the ratio of the activities of citrate
synthase and NADH–cytochrome c oxidoreductase was deter-
mined even in liver homogenates of eNOS-KO mice in com-
parison to liver homogenates of WT mice. However, this ratio
differed less between eNOS-KO and WT than between nNOS-
KO and WT [7]. This may result from the in-homogenous
distribution of mitochondria and fat in the livers of eNOS-KO
mice. The local excess of citrate would result in increased
cytosolic citrate concentration via the transport through the
mitochondrial membrane. This may cause stimulation of acetyl-
CoA formation by the ATP-dependent citrate lyase. Citrate
lyase is a key enzyme of fatty acid metabolism. Therefore, fatty
acid synthesis may be stimulated by increased generation of
citrate within the mitochondria. This may explain the local
association of mitochondria and fat droplets within the hepa-
tocytes and over the entire organ. As a second aspect, it is
reasonable to assume that the local concentration of oxygen
in liver differs between WT and eNOS-KO mice. In the liver
of WT mice the oxygen concentration is relatively high far
away from the artery (zone 3) since close to the artery (zone 1)
the mitochondrial oxygen consumption is limited due to NO-
dependent inhibition of cytochrome c oxidase. In contrast, in
the liver of eNOS-KO mice the oxygen concentration in zone 3
is low since some of the oxygen is consumed by the mito-
chondria in zone 1. In the liver of eNOS-KO mice the citric acid
cycle may generate more citrate that can be used for fatty acid
synthesis because restricted oxygen supply in zone 3 reduces
the activity of the electron transport chain. Besides changes in
the enzymatic pattern of mitochondria this may explain the
structured distribution of fat deposits in the liver of eNOS-KO
mice. In our previous report [7] we demonstrated accumulation
of total lipids in the livers of nNOS-KO mice in comparison to
WT mice. This increase in total lipids was not accompanied by
higher triacylglycerol and body weight (earlier own results,
Fig. 5). Increase in total lipids which are represented by free
fatty acids, phospholipids and triacylglycerol but not exclu-
sively in triacylglycerol may reflect a moderate drop in local
NO concentrations as can be reached by knocking out nNOS.
The observation that knocking out eNOS in mice causes the
architecture-dependent massive accumulation of fat in liver
may underline the dominant contribution of eNOS to local NO
concentration.
To study the zone-dependent lipid metabolism in the liver of
eNOS-KO mice in detail, hepatocytes or mitochondria from the
zones of the liver that display massive fat accumulation have to
be isolated. This separation would allow the comparison of
cytosolic accumulation of citrate and acetyl-CoA in zone 3 and
zone 1. Evaluation of nitrosilation of acetyl-CoA is of great
interest when values of zone 3 and zone 1 are compared ad-ditionally between eNOS-KO mice and WT mice. The same
material of the livers would be required in order to provide
conclusive data for a possible NO-dependent activation of AMP-
activated protein kinase in these mouse models. To date, suitable
methods with an adequate yield for the isolation of hepatocytes
and mitochondria from separate liver zones are not available.
We have also found higher amounts of glycogen deposits in
zone 1 and 3 of livers from eNOS-KO mice in comparison to
WT mice. It is known that NO dose-dependently inhibits glu-
coneogenesis [24] and glycogen synthesis at the level of the
glycogen synthase [25] in hepatocytes. The effect of NO on
gluconeogenesis is mediated by the activation of AMP-activated
protein kinase [26]. The accumulation of glycogen in the liver of
eNOS-KO mice is consistent with the lack of NO-inhibition on
carbohydrate metabolism.
Besides deposition of high amounts of fat in liver, eNOS-KO
mice exert massive accumulation of visceral fat obviously con-
tributing to higher body weights in comparison to WT mice.
The difference in body weight between eNOS-KO and WT
mice increased with age. Similar results were obtained in other
laboratories. At the age of 10 month, eNOS-KO mice have been
found to be 48% heavier than WT mice [27] whereas at lower
ages between 8–16 weeks either no [28,29] or small differences
in body weight were observed [30]. Higher body weights of
eNOS-KO mice in comparison to WT mice were also reported
by Nisoli et al. [8], but were mainly attributed to low energy turn
over due to less mitochondria. In comparison to the data of
Nisoli et al. [8] our mice grew slower. A reason for this discre-
pancy may be different environmental conditions. The animals
of the report of these authors were maintained at 24 °C whereas
our animals were hold at 21 °C. Here we report for the first
time that NO-dependent fat deposition is linked to mitochon-
drial metabolism in liver. This conclusion is based on the co-
localization of mitochondria and fat droplets, the distribution of
fat and mitochondria in dependence on the distance to the artery,
and changes in the ratio of the citrate synthase and NADH–
cytochrome c oxidoreductase activities. In contrast to Nisoli
et al. [8], we did not find differences in the quantity of liver
mitochondria between WT and eNOS-KO mice. One reason for
this discrepancy may be the different temperature at which the
animals were maintained.
Despite higher body weight, more visceral fat, and massive
fat deposition in the liver of eNOS-KO mice, we found similar
serum levels of triacylglycerol in WT and eNOS-KO mice.
Obviously, the capacity of the transport system for triacylgly-
cerol is not yet overloaded. In contrast, our data reveal that
serum insulin and glucose levels are lower in eNOS-KO mice.
In this context we speculate that the synthesis of glycogen and
triacylglycerol requires an increased ATP production. In turn,
this would cause acceleration of glucose consumption resulting
in lower serum glucose concentration combined with decrease
in insulin secretion.
It had been shown that NO is involved in the regulation of
the metabolism of glucose, fatty acids and amino acids in
mammals. A number of regulatory sites had been identified
[31]. With our data we add a yet unrecognized mechanism to the
NO-dependent regulation of lipid metabolism. It is the control
187L. Schild et al. / Biochimica et Biophysica Acta 1782 (2008) 180–187of the activity of mitochondrial enzymes which are involved in
fatty acid synthesis, namely CS and KI+III. Furthermore, our
data reveal that a defect in NO generation by eNOS contributes
to the development of overweight and obesity. Obesity is a
major risk factor for insulin resistance, type II diabetes, athero-
sclerosis, stroke, hypertension, impaired vascular function, sleep
disorders and some types of cancer [32].
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